The Diabetes & Obesity Division is Pharmatrade's dedicated therapeutic-area division, built around one of the fastest-growing areas of healthcare in the UAE.
The Diabetes & Obesity Division is Pharmatrade's dedicated therapeutic-area division, built around one of the fastest-growing areas of healthcare in the UAE. The division partners with leading global manufacturers: Eli Lilly, Sanofi, Roche and Embecta, to make innovative diabetes and obesity medicines and technologies available across the private and government sectors in Dubai, the Northern Emirates, Abu Dhabi and Al Ain.
OUR FOCUS
- Availability: ensuring reliable access to innovative diabetes and obesity treatments across the UAE.
- Patient journey: supporting patients from awareness and early screening through to treatment support.
- Partnership: working hand in hand with health authorities, healthcare providers, and our principals in line with UAE national health priorities.
LEADERSHIP:
The Diabetes & Obesity Division is led by a team with deep regional pharmaceutical experience, dedicated to bringing innovative diabetes and obesity solutions to patients across the UAE, in partnership with the country’s health authorities and leading healthcare providers.
